Erythroid response to treatment with G‐CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model von Hellström‐Lindberg, Eva, Negrin, Robert, Stein, Richard, Krantz, Sanford, Lindberg, Greger, Vardiman, James, ÖSt, ÅKe, Greenberg, Peter

Volltext

Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin von Hellström-Lindberg, E, Kanter-Lewensohn, L, Ost, A

Volltext

A combination of granulocyte colony-stimulating factor and erythropoietin may synergistically improve the anaemia in patients with myelodysplastic syndromes von Hellström-Lindberg, E, Birgegård, G, Carlsson, M, Carneskog, J, Dahl, I M, Dybedal, I, Grimfors, G, Merk, K, Tangen, J M, Winqvist, I

Volltext

G-CSF influence on apoptosis induced by ATRA and VP-16 in P39 cell line von Syruckova, Z, Forsblom, A, HellstromLindberg, E

Volltext

Effects of all-trans retinoic acid (ATRA), granulocyte-CSF (G-CSF) and erythropoietin (EPO) on in vitro apoptosis and proliferation in myelodysplastic bone marrow von HellstromLindberg, E, Forsblom, AM

Volltext

Recombinant human granulocyte‐macrophage colony‐stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes von Hansen, Per Boye, Johnsen, Hans E., Hippe, Erik, Hellström‐Lindberg, Eva, Ralfkiaer, Elisabeth

Volltext

Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes von Widell, S., Hellström‐Lindberg, E., Kock, Y., Lindberg, M., Öst, Å., Hast, R.

Volltext

Effects of G-CSF, EPO, SCF, ATRA and the CD 95 blocking antibody f(ab') 2 on in vitro apoptosis and proliferation in myelodysplastic (MDS) bone marrow von HellstromLindberg, E, Forsblom, AM, Syruckova, Z, Christensen, B

Volltext

Erythropoietic effectiveness and apoptosis in patients with myelodysplastic syndromes (MDS) treated with G-CSF and EPO von Kanter, L, HellstromLindberg, E, Kock, Y, Rodensjo, M, Ost, A

Volltext

INVITRO SUSPENSION-CULTURE REACTIONS TO 1,25 DIHYDROXYVITAMIN-D3 IN RELATION TO BONE-MARROW MORPHOLOGY AND PROGNOSIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES von HELLSTROMLINDBERG, E, ROBERT, KH, AHNSEN, B, ELMHORNROSENBORG, A, KOCK, Y, OST, A

Volltext

Variable growth in vitro of chromosomally different stem cells in myelodysplastic syndromes von Swolin, Birgitta, Högh Kristiansen, Inge, Rödjer, Stig, Hellström-Lindberg, Eva

Volltext

Low-Dose Ara-C in Myelodysplastic Syndromes (MDS) and Acute Leukemia Following MDS: Proposal for a Predictive Model von Hellström-Lindberg, Eva, Robèrt, Karl-Henrik, Gahrton, Gösta, Lindberg, Greger, Forsblom, Ann-Mari, Kock, Yvonne, Öst, åke

Volltext

Efficacy of G-CSF and EPO on the anaemia in patients with myelodysplastic syndromes (MDS) von HellstromLindberg, E, Negrin, R, Stein, R, Krantz, S, Vardiman, J, Ost, A, Lindberg, G, Greenberg, P

Volltext

Treatment of the anemia in MDS with G-CSF and EPO: Final report from a randomized phase II study von HellstromLindberg, E, Tangen, JM, Grimfors, G, Lindemalm, C, Carlsson, M, Oberg, G, Lowenberg, E, Linder, O, Dybedal, I, Dahl, IM, NilssonEhle, H, Ahlgren, T, Winquist, I, Carneskog, J, Luthman, M

Volltext

Randomized study comparing chemotherapy ±GM-CSF in high-risk MDS and AML following MDS (MDS-AML) von Ohm, AC, Hast, R, Bernell, P, Celsing, F, Dahl, IM, Dybedal, I, Lindberg, G, Linder, O, Lofvenberg, E, Nilsson-Ehle, H, Samuelsson, J, Tangen, J, Turesson, I, Wallvik, J, Winquist, I, Oberg, G, Bjorkholm, M, Hellstrom-Lindberg, E

Volltext